Investigating Different Frequencies of Transcranial Electrical Stimulations in Dementia Population
Launched by UNIVERSITY OF MANITOBA · Aug 6, 2024
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different types of electrical stimulation applied to the brain can help improve memory and thinking skills in older adults with dementia. The researchers want to find out which specific stimulation methods work best when combined with brain exercises. Participants in this study will be closely monitored using various technologies to track any changes in brain activity and balance during the treatment. This study is double-blind, meaning neither the participants nor the researchers know who is receiving the actual treatment versus a placebo (an inactive treatment), to ensure fair and accurate results.
To be eligible for this study, participants should be between 50 and 95 years old and have a certain level of cognitive impairment, as measured by a specific test. However, individuals with certain medical conditions, like Parkinson’s disease or severe mental health issues, will not be eligible. Participants can expect to attend sessions where they will receive the stimulation treatment and participate in cognitive exercises, all while being observed and assessed for changes in their memory, thinking, and balance. This research aims to contribute valuable insights into potential new treatments for dementia and will pave the way for future studies based on the findings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • MoCA score between 5 and 24
- • Between the age of 50 and 95 years old
- Exclusion Criteria:
- • Being diagnosed with Parkinson's, Parkinsonian dementia, Huntington disease, speech significant aphasia and intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder.
- • Having a History of epileptic seizures or epilepsy
- • Inability to adequately communicate in English
- • Impaired vision or hearing severe enough to impair performance in cognitive tests
- • Current substance abuse disorder
- • Currently participating in another therapeutic study for dementia
- • Change to medication for Alzheimer's disease, dementia, or depression
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported